Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies

Induction immunosuppressive therapy for kidney transplant recipients (KTRs) primarily includes interleukin-2 receptor antagonists, such as basiliximab (BXM) or lymphocyte-depleting agents, and anti-thymocyte globulin (ATG). This study aimed to investigate their effects on T cell dynamics during the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung Duk, Bae, Hyunjoo, Yun, Sojeong, Lee, Hanbi, Eum, Sang Hun, Yang, Chul Woo, Oh, Eun-Jee, Chung, Byung Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532255/
https://www.ncbi.nlm.nih.gov/pubmed/37762590
http://dx.doi.org/10.3390/ijms241814288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532255/
https://www.ncbi.nlm.nih.gov/pubmed/37762590
http://dx.doi.org/10.3390/ijms241814288

Ejemplares similares